Argent Biopharma logo
RGT
Pharmaceuticals, Biotechnology & Life Sciences

Argent Biopharma

Short interest
0.00%
0.00 pp 30d
as of 19 Aug 2024
Reported shorts
1
Shares on issue
48.406M

Argent Biopharma (RGT) company profile

Profile, insiders and operations

Company

AI-generated research profile of Argent Biopharma

biotechnology
pharmaceutical development
plant-based medicine
unmet medical needs
european pharmaceuticals

Argent Biopharma Limited is a European-based pharmaceuticals company that focuses on creating innovative plant-inspired medicines and treatments addressing unmet medical conditions. The firm leverages its unique expertise in extracting and processing natural compounds to produce pharmaceuticals that serve niche, underserved markets. With a strong research and development emphasis, Argent positions itself as a leader in naturally-derived pharmaceutical solutions, aiming to enhance treatment efficacy and patient safety.

Director trades

12 trades recorded

DateDirectorTypeSharesPriceValue
2026-04-10Gary Hermon
buy
1,000,000--
2026-04-10Unknown Director
buy
---
2024-10-15Roby Reuven Zomer
buy
4,000,000$0.410$1,640,000
2024-10-15Unknown Director
buy
---
2024-09-12Unknown Director
buy
---
2024-09-10Roby Reuven Zomer
buy
1,258,500$0.400$503,400
2024-07-08Unknown Director
buy
---
2024-06-30Roby Reuven Zomer
sell
4,900--
2024-03-28Layton Mills
buy
120,000--
2024-03-28Daniel Robinson
buy
120,000--
2024-03-28Unknown Director
buy
---
2024-03-28Unknown Director
buy
---

RGT intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required